Robert Duggan
Vermögen: 11 414 Mio $ am 31.05.2026
Vermögen: 11 414 Mio $ am 31.05.2026
Robert William Duggan ist ein Geschäftsmann, der Robert W. Duggan & Associates gegründet hat und der 9 verschiedene Unternehmen geleitet hat. Gegenwärtig ist Herr Duggan Chairman bei Pulse Biosciences, Inc, Executive Chairman & Chief Executive Officer bei Summit Therapeutics, Inc., Executive Chairman & Chief Executive Officer bei Summit Therapeutics Ltd. (eine Tochtergesellschaft von Summit Therapeutics, Inc.) und Chief Executive Officer von Duggan Investments Inc. Herr Duggan ist auch im Vorstand der University of California Santa Barbara Foundation, der Santa Barbara Foundation, MuOx Ltd. und Human Longevity, Inc. In seiner früheren Laufbahn war Herr Duggan Präsident von Robert W. Duggan & Associates, Chairman & Chief Executive Officer von Pharmacyclics LLC, Chairman & Chief Executive Officer für Computer Motion, Inc. sowie Chairman von Metropolis Media, Inc. und Chairman bei Communication Machinery Corp.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SUMMIT THERAPEUTICS INC 74.76% | 04.06.2026 | 580’273’655 ( 74.76% ) | 10 178 Mio $ | 31.05.2026 |
PULSE BIOSCIENCES, INC. 71.45% | 11.05.2026 | 49’450’345 ( 71.45% ) | 1 236 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PULSE BIOSCIENCES, INC. | Vorsitzender | 02.11.2017 |
| SUMMIT THERAPEUTICS INC. | Vorstandsvorsitzender | 01.04.2020 |
Duggan Investments Inc. | Vorstandsvorsitzender | 01.01.2015 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Vorstandsvorsitzender | 14.04.2020 |
Santa Barbara Foundation
Santa Barbara Foundation Miscellaneous Commercial ServicesCommercial Services Foundation | Direktor/Vorstandsmitglied | - |
Human Longevity, Inc.
Human Longevity, Inc. BiotechnologyHealth Technology Provides genomics and cell therapy-based diagnostic and therapeutic services | Direktor/Vorstandsmitglied | - |
University of California Santa Barbara Foundation
University of California Santa Barbara Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Develops antibiotics and drug-resistant pathogens | Direktor/Vorstandsmitglied | 27.05.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
MuOx Ltd.
MuOx Ltd. BiotechnologyHealth Technology Develops utrophin modulators and biological screening equipment | Direktor/Vorstandsmitglied | 06.06.2023 |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 17 |
|---|---|
AM-CH, Inc.
AM-CH, Inc. RestaurantsConsumer Services Owns and operates restaurants | Consumer Services |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Computer Motion, Inc.
Computer Motion, Inc. Medical SpecialtiesHealth Technology Develops and manufactures computer-enhanced robotic surgical systems | Health Technology |
Intuitive Surgical, Inc.
Intuitive Surgical, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets robotic surgical systems | Health Technology |
UNICOM Government, Inc.
UNICOM Government, Inc. Electronics DistributorsDistribution Services Provides technology solutions and professional services to federal, state and local governments | Distribution Services |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Health Technology |
Pulse Biosciences, Inc.
Pulse Biosciences, Inc. Medical SpecialtiesHealth Technology Operates as a bioelectric medicine company which develops medical devices | Health Technology |
Metropolis Media, Inc.
Metropolis Media, Inc. Publishing: NewspapersConsumer Services Publishes newspapers | Consumer Services |
Communication Machinery Corp.
Communication Machinery Corp. Packaged SoftwareTechnology Services Develops wireless communications network testing products and equipment | Technology Services |
University of California Santa Barbara Foundation
University of California Santa Barbara Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Robert W. Duggan & Associates
Robert W. Duggan & Associates Investment ManagersFinance Provides investment advice | Finance |
Santa Barbara Foundation
Santa Barbara Foundation Miscellaneous Commercial ServicesCommercial Services Foundation | Commercial Services |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Develops antibiotics and drug-resistant pathogens | Health Technology |
MuOx Ltd.
MuOx Ltd. BiotechnologyHealth Technology Develops utrophin modulators and biological screening equipment | Health Technology |
Human Longevity, Inc.
Human Longevity, Inc. BiotechnologyHealth Technology Provides genomics and cell therapy-based diagnostic and therapeutic services | Health Technology |
Duggan Investments Inc. | |
Summit Therapeutics, Inc.
Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen